US Vaccines GTM Strategy & Innovation Director/Sr. Director (Secondment 12-18 Months)

Pfizer•New York City, NY

5d•Hybrid

About The Position

The U.S. Vaccines business unit is a critical strategic pillar of Pfizer’s commercial portfolio, representing the largest collective impact on population health and substantial contribution to enterprise revenues and earnings. Our Vaccines protect millions of lives every year across every stage of life. Our inline and pipeline products represent a key part of Pfizer’s renewed strategy for 2030 and beyond. Today, U.S. Vaccines are largely administered within two ‘traditional’ channels – at point of care (in HCP offices and health systems) and via retail pharmacy. However, driven by numerous factors, vaccination rates have consistently fallen year over year in the past 5 years, culminating in double-digit declines in the latest northern hemisphere winter ‘season’ of administrations. At the same time, intense competition across categories and the involvement of multiple intermediary actors are driving pricing erosion, placing significant pressure on vaccine margins and limiting ability to reinvest in the next generation of breakthrough vaccines. To meet the urgency this moment demands, US Vaccines has established a priority ‘Go to Market Innovation’ program, led by a Pilot in Command, under executive sponsorship by the U.S. Commercial Division, U.S. Primary Care and U.S. Vaccines, tasked with establishing transformative routes to market that will appropriately increase vaccine administration rates and sustain vaccines innovation. In partnership with the Pilot in Command, this colleague will own building Fall 2026 pilot(s) to support Vx GTM innovation —collaborating with external parties to turn a partnership into a live, working channel model, driving it to proof, and translating into the analytics and multi-year strategy that scale it. This role will primarily focus on the end-to-end exploration, pilot, and longer-term ecosystem surrounding blood draw sites and will report into Susan Schneps (PIC).

Requirements

Bachelor's degree with at least 12+ years of experience.
Demonstrated track record of strategic planning, innovation, and operational execution, with the ability to translate vision into action and deliver measurable business outcomes.
In-depth knowledge of the U.S. healthcare landscape, including channels to market and current and prospective business partners across the ecosystem.
Strong leadership acumen, agility, and communication skills are required, along with the ability to influence stakeholders and drive alignment in complex environments.
A strong understanding of the U.S. marketing landscape is essential, including experience with HCP, pharmacy, medical group/integrated delivery network, and payer engagement strategies.
Demonstrated matrix leadership capabilities and a proven ability to foster collaboration and successful delivery across diverse cross-functional teams.
Actively contribute to creating and operating in an environment that embraces bold thinking, innovation, and continuous improvement.
Excellent communication and organizational skills are required and should be evidenced by meaningful impact and success in prior roles.
Consistently demonstrate and serve as a role model for Pfizer values.
Permanent work authorization in the United States.

Nice To Haves

Master's degree with at least 10+ years of experience; OR a PhD with 7+ years of experience; OR a MD with 5+ years of experience.
Marketing and/or external partnership experience is preferred, including experience building, launching, and operating initiatives with external partners.
Customer-facing experience, such as an account director role or a similar hands-on external partnership position, is highly desirable.
Experience with U.S. access, payer, and contracting environments is a plus, as emerging channel models may involve standing orders, reimbursement considerations, and economic value propositions.
Strong strategic thinker with demonstrated analytical capabilities and is comfortable leading opportunity sizing, geo-targeting, and segmentation efforts.
Ability to build the plan while simultaneously executing it and adapting as new information emerges.

Responsibilities

Stand up and operationalize pilot models with external partners, defining workflows, roles and responsibilities, site selection logic, governance structures, and success metrics to ensure effective execution and measurable outcomes.
Lead Fall 2026 pilot model(s) end to end, establishing scope, milestones, decision points, and go/no-go criteria while driving the initiative toward a defensible proof of concept that can inform future scaling decisions.
Lead opportunity sizing, targeting, and segmentation efforts, translating pilot learnings into clear, data-driven recommendations that support future investment and growth decisions.
Help shape the longer-term (2027+) channel roadmap by evaluating which channels to pursue, the optimal sequencing of investments, and the potential scale and impact of each opportunity.
Explore and advance new channel opportunities, including both entirely new approaches and enhancements to existing operational models, to support growth beyond 2027.